The Mycobactin biosynthesis pathway: A prospective therapeutic target in the battle against tuberculosis

M Shyam, D Shilkar, H Verma, A Dev… - Journal of Medicinal …, 2020 - ACS Publications
The alarming rise in drug-resistant clinical cases of tuberculosis (TB) has necessitated the
rapid development of newer chemotherapeutic agents with novel mechanisms of action. The …

Chromanone-A prerogative therapeutic scaffold: an overview

S Kamboj, R Singh - Arabian journal for science and engineering, 2022 - Springer
Chromanone or Chroman-4-one is the most important and interesting heterobicyclic
compound and acts as a building block in medicinal chemistry for isolation, designing and …

Arylcarboxylation of unactivated alkenes with CO2 via visible-light photoredox catalysis

W Zhang, Z Chen, YX Jiang, LL Liao, W Wang… - Nature …, 2023 - nature.com
Photocatalytic carboxylation of alkenes with CO2 is a promising and sustainable strategy to
synthesize high value-added carboxylic acids. However, it is challenging and rarely …

In Silico Strategies in Tuberculosis Drug Discovery

SJY Macalino, JB Billones, VG Organo, MCO Carrillo - Molecules, 2020 - mdpi.com
Tuberculosis (TB) remains a serious threat to global public health, responsible for an
estimated 1.5 million mortalities in 2018. While there are available therapeutics for this …

Iron acquisition and metabolism as a promising target for antimicrobials (bottlenecks and opportunities): where do we stand?

G Stelitano, M Cocorullo, M Mori, S Villa… - International Journal of …, 2023 - mdpi.com
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections
is one of the most crucial challenges currently faced by the scientific community …

Targeting Mycobacterium tuberculosis iron-scavenging tools: A recent update on siderophores inhibitors

G Kumar, PA Adhikrao - RSC Medicinal Chemistry, 2023 - pubs.rsc.org
Among the various bacterial infections, tuberculosis (TB) remains a life-threatening
infectious disease responsible as the most significant cause of mortality and morbidity …

Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery

S Perveen, R Sharma - Biochemical Pharmacology, 2022 - Elsevier
Tuberculosis (TB) is an infectious disease, infecting a quarter of world's population. Drug
resistant TB further exacerbates the grim scenario of the drying TB drug discovery pipeline …

Synthesis, characterization, and biological evaluation of new derivatives targeting MbtI as antitubercular agents

M Mori, G Stelitano, LR Chiarelli, G Cazzaniga… - Pharmaceuticals, 2021 - mdpi.com
Tuberculosis (TB) causes millions of deaths every year, ranking as one of the most
dangerous infectious diseases worldwide. Because several pathogenic strains of …

Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae

AD Meca, L Mititelu-Tarțău, M Bogdan… - Journal of personalized …, 2022 - mdpi.com
Tuberculosis (TB) is still a worldwide public health burden, as more than 1.3 million deaths
are expected to be reported in 2021. Even though almost 20 million patients have completed …

Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design

M Mori, G Stelitano, A Gelain, E Pini… - Journal of Medicinal …, 2020 - ACS Publications
The Mg2+-dependent Mycobacterium tuberculosis salicylate synthase (MbtI) is a key
enzyme involved in the biosynthesis of siderophores. Because iron is essential for the …